{"id":11251,"date":"2024-03-07T09:24:19","date_gmt":"2024-03-07T08:24:19","guid":{"rendered":"https:\/\/kloepfel.sempre-diritto.de\/2024\/03\/07\/bayer-will-performance-steigern\/"},"modified":"2025-08-27T11:24:19","modified_gmt":"2025-08-27T09:24:19","slug":"bayer-will-boost-performance","status":"publish","type":"post","link":"https:\/\/kloepfel-consulting.com\/en\/2024\/03\/07\/bayer-will-performance-steigern\/","title":{"rendered":"Bayer aims to improve performance"},"content":{"rendered":"

Reduce debt, realign organisational model, reduce legal risks<\/h2>\n

The company, which is currently under intense public scrutiny Bayer Group<\/a> CEO Bill Anderson made a forward-looking statement on Tuesday during the annual press conference in London.<\/p>\n

The Leverkusen-based pharmaceutical and agrochemical company reported that its adjusted Goals<\/strong> for the 2023 financial year. The CEO said: \u201eWe are a high-impact life science company driven by a great mission and we have three strong divisions.\u201c However, he also pointed out that there was an urgent need for action in several areas.<\/p>\n

Organisational model - no split<\/h3>\n

According to its press release, Bayer intends to build a strong pharmaceutical pipeline, reduce legal risks and lower debt over the next 24 to 36 months. The Group also intends to further introduce the new organisational model called Shared Ownership (DSO). For this Organisational model<\/em>, Bayer had already decided several weeks ago in favour of a new corporate strategy that would reduce hierarchies, eliminate bureaucracy and speed up decision-making processes.<\/p>\n

The plans presented on Tuesday are intended to improve the Group's overall performance. According to his explanations, Bayer intends to focus intensively on customers and products and to be leaner and more effective than its competitors in every area of the company's business.<\/p>\n

In order to reduce the legal risks and associated uncertainties, the company says it will adapt its strategy and pursue new approaches both inside and outside the courts.<\/p>\n

Bill Anderson has at this stage rejected the idea of splitting up the Bayer Group, as is currently often publicly demanded. However, Anderson said: \u201eOf course we will remain open to everything.\u201c<\/p>\n

Lower sales<\/h3>\n

In 2023, Group sales adjusted for currency and portfolio effects (Fx & portfolio adj.) fell by 1.2 per cent compared to the previous year to around 47.63 billion euros. EBITDA pre exceptionals fell by 13.4 per cent to around EUR 11.70 billion. The EBITDA margin pre exceptionals reached 24.6 per cent. It was therefore 2 percentage points lower in 2023 than in 2022.<\/p>\n

Outlook<\/h3>\n

For the current year, Bayer expects currency-adjusted sales of between 47 billion and 49 billion euros. Bayer believes that EBITDA pre exceptionals may be between EUR 10.7 billion and EUR 11.3 billion after adjusting for currency effects. With regard to net financial debt, the Group expects a figure of between EUR 32.5 billion and EUR 33.5 billion (currency-adjusted) at the end of 2024.<\/p>","protected":false},"excerpt":{"rendered":"

Schulden abbauen, Organisationsmodell neu ausrichten, rechtliche Risiken reduzieren Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert. Der Leverkusener Pharma- und Agrarchemiekonzern berichtete, seine angepassten Ziele f\u00fcr das Gesch\u00e4ftsjahr 2023 erreicht zu haben. Der Vorstandsvorsitzende sagte: \u201eWir sind ein Life-Science-Unternehmen mit hoher […]<\/p>\n","protected":false},"author":1,"featured_media":11252,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[88],"tags":[],"referenzkategorie":[],"class_list":["post-11251","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-supply-chain-news"],"acf":[],"yoast_head":"\nBayer will Performance steigern<\/title>\n<meta name=\"description\" content=\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/kloepfel-consulting.com\/en\/2024\/03\/07\/bayer-aims-to-boost-performance__trashed\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Bayer will Performance steigern\" \/>\n<meta property=\"og:description\" content=\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/kloepfel-consulting.com\/en\/2024\/03\/07\/bayer-aims-to-boost-performance__trashed\/\" \/>\n<meta property=\"og:site_name\" content=\"KLOEPFEL by EPSA\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/KloepfelGroup\" \/>\n<meta property=\"article:published_time\" content=\"2024-03-07T08:24:19+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-08-27T09:24:19+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"2200\" \/>\n\t<meta property=\"og:image:height\" content=\"1608\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"semprediritto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"Bayer: Performance-Steigerung 2023\" \/>\n<meta name=\"twitter:description\" content=\"Erfahren Sie mehr \u00fcber Bayers neue Strategien zur Performance-Steigerung und Schuldenabbau.\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"semprediritto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/\"},\"author\":{\"name\":\"semprediritto\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\"},\"headline\":\"Bayer will Performance steigern\",\"datePublished\":\"2024-03-07T08:24:19+00:00\",\"dateModified\":\"2025-08-27T09:24:19+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/\"},\"wordCount\":376,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"articleSection\":[\"Supply Chain News\"],\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#respond\"]}],\"copyrightYear\":\"2024\",\"copyrightHolder\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/en\\\/#organization\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/\",\"name\":\"Bayer will Performance steigern\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"datePublished\":\"2024-03-07T08:24:19+00:00\",\"dateModified\":\"2025-08-27T09:24:19+00:00\",\"description\":\"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#primaryimage\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/08\\\/Bayer-Aspirin-tablet-e1709729442299.jpg\",\"width\":1941,\"height\":1346,\"caption\":\"Runde Bayer Aspirin Tablette auf blauer Fl\u00e4che.\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/2024\\\/03\\\/07\\\/bayer-will-performance-steigern__trashed\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Bayer will Performance steigern\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#website\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"name\":\"KLOEPFEL by EPSA\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\"},\"alternateName\":\"KLOEPFELbyEPSA\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/kloepfel-consulting.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#organization\",\"name\":\"KLOEPFEL by EPSA\",\"alternateName\":\"KLOEPFELbyEPSA\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"contentUrl\":\"https:\\\/\\\/kloepfel-consulting.com\\\/wp-content\\\/uploads\\\/2025\\\/04\\\/logo.webp\",\"width\":616,\"height\":284,\"caption\":\"KLOEPFEL by EPSA\"},\"image\":{\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/KloepfelGroup\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/kloepfel-consulting-gmbh\",\"https:\\\/\\\/www.instagram.com\\\/kloepfel_by_epsa\\\/\"],\"description\":\"Einkaufsberatung f\u00fcr Einkauf, Logistik und Supply Chain\",\"email\":\"info@kloepfel-consulting.com\",\"telephone\":\"+4921194198433\",\"legalName\":\"Kloepfel Consulting GmbH\",\"foundingDate\":\"2007-02-01\",\"vatID\":\"DE254132249\",\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":\"51\",\"maxValue\":\"200\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/kloepfel-consulting.com\\\/#\\\/schema\\\/person\\\/2691163984d9670e417622b00a4c0f26\",\"name\":\"semprediritto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g\",\"caption\":\"semprediritto\"},\"sameAs\":[\"https:\\\/\\\/kloepfel.sempre-diritto.de\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Bayer aims to improve performance","description":"At the Bayer Group, which is currently under heavy public scrutiny, CEO Bill Anderson commented on Tuesday","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/kloepfel-consulting.com\/en\/2024\/03\/07\/bayer-aims-to-boost-performance__trashed\/","og_locale":"en_GB","og_type":"article","og_title":"Bayer will Performance steigern","og_description":"Beim aktuell stark unter \u00f6ffentlicher Beobachtung stehenden Bayer-Konzern \u00e4u\u00dferte sich der Vorstandsvorsitzende Bill Anderson am Dienstag w\u00e4hrend der Bilanz-Pressekonferenz in London zukunftsorientiert.","og_url":"https:\/\/kloepfel-consulting.com\/en\/2024\/03\/07\/bayer-aims-to-boost-performance__trashed\/","og_site_name":"KLOEPFEL by EPSA","article_publisher":"https:\/\/www.facebook.com\/KloepfelGroup","article_published_time":"2024-03-07T08:24:19+00:00","article_modified_time":"2025-08-27T09:24:19+00:00","og_image":[{"width":2200,"height":1608,"url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/07\/kloepfelgroup.webp","type":"image\/webp"}],"author":"semprediritto","twitter_card":"summary_large_image","twitter_title":"Bayer: Performance-Steigerung 2023","twitter_description":"Erfahren Sie mehr \u00fcber Bayers neue Strategien zur Performance-Steigerung und Schuldenabbau.","twitter_misc":{"Written by":"semprediritto","Estimated reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#article","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/"},"author":{"name":"semprediritto","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26"},"headline":"Bayer will Performance steigern","datePublished":"2024-03-07T08:24:19+00:00","dateModified":"2025-08-27T09:24:19+00:00","mainEntityOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/"},"wordCount":376,"commentCount":0,"publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","articleSection":["Supply Chain News"],"inLanguage":"en-GB","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#respond"]}],"copyrightYear":"2024","copyrightHolder":{"@id":"https:\/\/kloepfel-consulting.com\/en\/#organization"}},{"@type":"WebPage","@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/","url":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/","name":"Bayer aims to improve performance","isPartOf":{"@id":"https:\/\/kloepfel-consulting.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#primaryimage"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#primaryimage"},"thumbnailUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","datePublished":"2024-03-07T08:24:19+00:00","dateModified":"2025-08-27T09:24:19+00:00","description":"At the Bayer Group, which is currently under heavy public scrutiny, CEO Bill Anderson commented on Tuesday","breadcrumb":{"@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#primaryimage","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/08\/Bayer-Aspirin-tablet-e1709729442299.jpg","width":1941,"height":1346,"caption":"Runde Bayer Aspirin Tablette auf blauer Fl\u00e4che."},{"@type":"BreadcrumbList","@id":"https:\/\/kloepfel-consulting.com\/2024\/03\/07\/bayer-will-performance-steigern__trashed\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/kloepfel-consulting.com\/"},{"@type":"ListItem","position":2,"name":"Bayer will Performance steigern"}]},{"@type":"WebSite","@id":"https:\/\/kloepfel-consulting.com\/#website","url":"https:\/\/kloepfel-consulting.com\/","name":"KLOEPFEL by EPSA","description":"","publisher":{"@id":"https:\/\/kloepfel-consulting.com\/#organization"},"alternateName":"KLOEPFELbyEPSA","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/kloepfel-consulting.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-GB"},{"@type":"Organization","@id":"https:\/\/kloepfel-consulting.com\/#organization","name":"KLOEPFEL by EPSA","alternateName":"KLOEPFELbyEPSA","url":"https:\/\/kloepfel-consulting.com\/","logo":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/","url":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","contentUrl":"https:\/\/kloepfel-consulting.com\/wp-content\/uploads\/2025\/04\/logo.webp","width":616,"height":284,"caption":"KLOEPFEL by EPSA"},"image":{"@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/KloepfelGroup","https:\/\/www.linkedin.com\/company\/kloepfel-consulting-gmbh","https:\/\/www.instagram.com\/kloepfel_by_epsa\/"],"description":"Purchasing Advice for Procurement, Logistics, and Supply Chain","email":"info@kloepfel-consulting.com","telephone":"+4921194198433","legalName":"Kloepfel Consulting GmbH","foundingDate":"2007-02-01","vatID":"DE254132249","numberOfEmployees":{"@type":"QuantitativeValue","minValue":"51","maxValue":"200"}},{"@type":"Person","@id":"https:\/\/kloepfel-consulting.com\/#\/schema\/person\/2691163984d9670e417622b00a4c0f26","name":"Always right","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/878f3ddb8fa2117ffa32d8a3152e4368517da61e3b89dd9bbfe39501477bf1f1?s=96&d=mm&r=g","caption":"semprediritto"},"sameAs":["https:\/\/kloepfel.sempre-diritto.de"]}]}},"_links":{"self":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11251","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/comments?post=11251"}],"version-history":[{"count":2,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11251\/revisions"}],"predecessor-version":[{"id":14591,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/posts\/11251\/revisions\/14591"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/media\/11252"}],"wp:attachment":[{"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/media?parent=11251"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/categories?post=11251"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/tags?post=11251"},{"taxonomy":"referenzkategorie","embeddable":true,"href":"https:\/\/kloepfel-consulting.com\/en\/wp-json\/wp\/v2\/referenzkategorie?post=11251"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}